Burden of Alzheimer Disease and Key Stakeholders Involved in Care

Panelists discuss how the growing prevalence of Alzheimer disease (AD) has created significant clinical, emotional, and financial burdens for patients, caregivers, and health systems. They examine how demographic shifts, improved longevity, and rising awareness have expanded the need for specialized services and multidisciplinary care coordination. The discussion highlights the strain placed on neurology practices and primary care providers, as the number of patients far exceeds available specialist capacity.

Panelists discuss how a broad network of stakeholders—including physicians, advanced practice providers (APPs), pharmacists, payers, and caregivers—must collaborate to meet the challenges of AD management. The conversation emphasizes that success depends on communication among these parties, ensuring timely diagnosis, consistent follow-up, and alignment on treatment objectives and patient education.

Panelists discuss how APPs serve as critical partners in this ecosystem, bridging gaps between patients and physicians. Their involvement enhances access, continuity, and patient engagement. The segment concludes by calling for better resource allocation and system-level planning to mitigate the far-reaching effects of AD on both individuals and society.